×
App Icon
The Standard e-Paper
Fearless, Trusted News
★★★★ - on Play Store
Download App

Personalised cancer vaccine cuts melanoma recurrence risk in trial

Acral lentigenous melanoma of the toe. Acral lentiginous melanoma of the left hallux (ALM), Clark index IV in a 69-year-old man. [AFP]

A personalised cancer vaccine has shown promising results in reducing the risk of melanoma returning or spreading after surgery.

This marks a potential breakthrough in the treatment of high-risk skin cancer.

Premium Article

Get Full Access for Ksh299/Week.

Uncover the stories others won't tell. Subscribe now for exclusive access.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902